The SOIC Podcast

The ETF King of India

42 min · 3 mei 2026
aflevering The ETF King of India artwork

Beschrijving

Send us Fan Mail [https://www.buzzsprout.com/1808526/fan_mail/new] In this episode, we break down Nippon India Asset Management Company and the rapidly growing asset management industry in India. We explore its strong financials, market share gains, and ETF leadership, along with the mental model behind successful AMCs. The discussion covers business model, growth drivers like SIP and passive investing, product mix, and competitive positioning. We also evaluate key risks and valuation to understand whether this is a long-term compounder in the making. If you want to understand how AMC businesses grow and how to identify high-quality compounders early, this episode is worth your time.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de The SOIC Podcast community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

97 afleveringen

aflevering One EV beneficiary? artwork

One EV beneficiary?

Send us Fan Mail [https://www.buzzsprout.com/1808526/fan_mail/new] In this episode, we break down Minda Corporation and the broader Auto Ancillary industry using six key mental models that help identify winning businesses. We analyze the company’s business model, product portfolio, JV-led growth strategy, EV opportunities, premiumization trends, FY30 growth ambitions, competitive positioning, risks, and valuation. We also compare Minda Corporation with peers like Uno Minda, Lumax Auto Technologies, Pricol, SJS Enterprises, and Samvardhana Motherson to understand the industry's evolving landscape. 👉 If you want to understand how to identify high-quality auto ancillary businesses and evaluate long-term growth opportunities in India's automotive ecosystem, this episode is worth your time.

Gisteren45 min
aflevering AI proof IT Business artwork

AI proof IT Business

Send us Fan Mail [https://www.buzzsprout.com/1808526/fan_mail/new] In this episode, we analyze Indegene, a Life Sciences and Pharma-focused IT services company, and explore how AI is reshaping the IT industry. We discuss the right mental model for evaluating IT companies, the difference between horizontal and vertical IT businesses, outcome-based pricing, revenue per employee, business segments, growth drivers, financial performance, risks, and valuation. The episode also highlights why Indegene may benefit from AI through domain expertise, regulatory capabilities, and productivity gains. 👉 If you want to understand the future of IT services and identify businesses that can benefit from AI rather than be disrupted by it, this episode is worth your time.

7 jun 202640 min
aflevering When will the Bull Market Start? Q4FY26 Earnings Check artwork

When will the Bull Market Start? Q4FY26 Earnings Check

Send us Fan Mail [https://www.buzzsprout.com/1808526/fan_mail/new] In this SOIC earnings special, we analyze the latest quarterly results across 1,400+ Indian companies and identify where growth is emerging beyond the major indices. We discuss key themes shaping the market, including sector rotation, manufacturing, healthcare, pharma, CDMO, defense, and precision engineering, along with standout performers such as Shilpa Medicare, Gland Pharma, Thangamayil, Astra Microwave, and others. The episode also explores why the next generation of wealth creators may emerge outside the Nifty 50 and what investors should watch in the coming quarters. 👉 If you want to understand where earnings growth is accelerating and identify tomorrow’s potential winners before they enter the index, this episode is worth your time.

31 mei 202629 min
aflevering A Hidden Indian Company Inside Every Protein Shake, Bakery & Tablet You Consume!! artwork

A Hidden Indian Company Inside Every Protein Shake, Bakery & Tablet You Consume!!

Send us Fan Mail [https://www.buzzsprout.com/1808526/fan_mail/new] In this episode, we deep dive into Sudeep Pharma and understand why it stands out as a high-margin business in the pharma and specialty ingredients industry. We discuss the company’s business model, excipient and nutrition segments, battery chemicals opportunity, CAPEX plans, moat, and key risk factors. The episode also compares Sudeep Pharma with companies like Vinati Organics and Clean Science and Technology to understand margin sustainability and competitive advantages.  If you want to understand high-margin B2B pharma businesses and identify companies with strong moats and long-term growth potential, this episode is worth your time.

24 mei 202650 min